Partner Headlines - MDVN

  1. Microsoft, GoPro And 8 More Stocks To Watch Over The Weekend

    Benzinga
  2. Medivation to Present at Leerink Partners 5th Annual Global Healthcare ...

    GuruFocus
  3. Journal of Clinical Oncology Publishes Results From the STRIVE ...

    GuruFocus
  4. Weekly Insider Sells: Medivation, JPMorgan Chase, Stryker, Sabre

    GuruFocus
  5. Lancet Oncology Publishes Results From the Phase 2 TERRAIN Trial ...

    GuruFocus
  6. NanoString Technologies Enters Into Collaboration Agreement With ...

    GuruFocus
  7. Medivation to Present at J.P. Morgan Healthcare Conference

    GuruFocus
  8. Medivation Initiates Pivotal Clinical Trial of MDV9300 in Diffuse ...

    GuruFocus
  9. Wild Short Interest Swings For Three Top Biotech Stocks

    Benzinga
  10. Medivation Announces Third Quarter 2015 Financial Results Teleconference ...

    GuruFocus
  11. Medivation Announces Management Changes

    GuruFocus
  12. Medivation Effects a Stock Dividend on Its Common Stock

    GuruFocus
  13. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga
  14. A Portfolio To Support Cancer Treatments In Time For Prostate ...

    Benzinga
  15. Medivation Announces Participation at Upcoming Investor Conference

    GuruFocus
  16. Benzinga's Top Initiations

    Benzinga
  17. Medivation to Expand Global Oncology Franchise With the Acquisition ...

    GuruFocus
  18. Benzinga's M&A Chatter for Monday August 24, 2015

    Benzinga
  19. Medivation to Expand Global Oncology Franchise With the Acquisition ...

    Benzinga
  20. Benzinga's Top #PreMarket Gainers

    Benzinga
  21. Medivation Voted Three Years in a Row Among Top Workplaces in ...

    GuruFocus
  22. UPDATE: Medivation, Astellas Report Enrollment of First Patients ...

    Benzinga
  23. New Enzalutamide Data in Triple-Negative Breast Cancer Presented ...

    Benzinga
  24. Stocks: A Soft Jump On Jobs Data; WhiteWave, Boeing, NXP Climb

    IBD
  25. Top Drugmaker Profits Mixed

    IBD
  26. Medivation, Jazz Q1 Reports Miss; Regeneron Beats

    IBD
  27. Four Hot Stocks You'll Want To Keep On Your Radar

    IBD
  28. Nasdaq, S&P 500 Hang Tough; Avago, Akorn Big Earnings Winners

    IBD
  29. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD
  30. Stocks Mixed; United Therapeutics Jumps To New High

    IBD
  31. Market Edges Higher, Unfazed By Weak HP Results

    IBD
  32. Market's Resilience Is Noteworthy; More Breakouts Emerge

    IBD
  33. Earnings Scheduled For February 25, 2015

    Benzinga
  34. Stocks Show Small Losses; Merger Talk Lifts Discovery

    IBD
  35. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD
  36. Wedbush Weighs in on Medivation Following Phase II TERRAIN Study ...

    GuruFocus
  37. Valeant Agrees To Buy Dendreon's Provenge

    IBD
  38. Weekly CEO Sells Highlight: QAD Inc, Orbitz Worldwide Inc, Constellation ...

    GuruFocus
  39. Enzalutamide Phase 2 Terrain Trial Demonstrated Statistically ...

    GuruFocus
  40. J&J Earnings Beat, But Sales, Guidance Miss Estimates

    IBD
  41. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD
  42. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  43. Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market

    Benzinga
  44. William Blair's Top BioPharmaceutical Stock Picks for Q1 2015

    GuruFocus
  45. Newly Profitable Medivation Riding High On Drug Sales

    IBD
  46. Chip Stocks, Biotechs Lead Another Nasdaq Rally

    IBD
  47. Major Upgrades And Downgrades In Friday's Market Action

    Benzinga
  48. Medivation Hits High After Q3 Earnings Beat

    IBD
  49. Medivation Hits High After Q3 Earnings Beat

    IBD
  50. Medivation and Astellas Announce Phase 3 Study of Enzalutamide ...

    GuruFocus
  51. J&J Earnings Beat; Olysio Chatter Hits Gilead

    IBD
  52. Consider Medivation for Your Portfolio

    FoxBusiness
  53. Benzinga's Top Downgrades

    Benzinga
  54. Goldman Sachs Downgrades Medivation To Neutral, Shares Drop

    Benzinga
  55. These 3 Biotech Stocks Just Hit New Highs

    Benzinga
  56. Fast Money Halftime Report Final Trade From September 12

    Benzinga
  57. Medivation Eyes Blockbuster As Cancer Drug Gets An OK

    IBD
  58. Stifel Raises Medivation Inc Price Target

    Benzinga
  59. Stocks Hitting 52-Week Highs

    Benzinga
  60. A Few Reasons Why Investors Should Consider Dendreon for Their ...

    GuruFocus
  61. Medivation Cancer Drug Fuels Beat, Swings To Profit

    IBD
  62. Benzinga's Volume Movers

    Benzinga
  63. Medivation Announces Change in Executive Management Team; Dawn ...

    Benzinga
  64. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  65. Aegis Capital Believes Seragon Deal Underscores Value In Medivation

    Benzinga
  66. UPDATE: Stifel Reiterates On Medivation Following Prostate Cancer ...

    Benzinga
  67. Benzinga's Top Upgrades

    Benzinga
  68. US Stock Futures Flat Ahead Of International Trade Data

    Benzinga
  69. UPDATE: Canaccord Genuity Initiates Coverage on Medivation as ...

    Benzinga
  70. Morning Market Movers

    Benzinga
  71. Stocks To Watch For April 1, 2014

    Benzinga
  72. Celegene, Pharmacyclics Lead Biotech Short Interest Trend (CELG, ...

    Benzinga
  73. UPDATE: Astellas Announces Marketing Approval in Japan for XTANDI® ...

    Benzinga
  74. BioMarin, Medivation Buck Biotech Short Interest Trend (BIIB, ...

    Benzinga
  75. Market Wrap For February 28: Markets Unable To Hold On To Gains

    Benzinga
  76. Mornings Movers for Feb. 28, 2014: CETV, OTVI, MELI, REGI, GALE ...

    Benzinga
  77. Benzinga's Top #PreMarket Losers

    Benzinga
  78. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  79. Mid-Afternoon Market Update: Fed Will Continue the Taper in February

    Benzinga
  80. Mid-Day Market Update: Yahoo! Slips After Q4 Results; RF Micro ...

    Benzinga
  81. New Year Short Interest Swings In Biotech (BIIB, BMRN, MDVN)

    Benzinga
  82. Mid-Morning Market Update: Markets Open Lower; Dow Chemical Posts ...

    Benzinga
  83. Stocks Hitting 52-Week Highs

    Benzinga
  84. Benzinga's Top #PreMarket Gainers

    Benzinga
  85. Medivation and Astellas Announce Final Results From the Phase ...

    Benzinga
  86. UPDATE: Aegis Capital Reiterates on Medivation Following In-Line ...

    Benzinga
  87. Medivation, Astellas Announce Phase 3 PREVAIL Trial of Enzalutamide ...

    Benzinga
  88. Uh Oh: Is This Cancer Highflyer In Your Account?

    YCharts
  89. Worse-Than-Expected Xtandi Sales Hitting Shares of Medivation; ...

    Benzinga
  90. Medivation Elects Kathryn Falberg to Board of Directors

    Benzinga
  91. Medivation Bulls Load Up on Call Options

    SchaeffersResearch
  92. Aegis Capital Corp. Reiterates Buy Rating, $100 PT on Medivation

    Benzinga
  93. Medivation, Inc. (MDVN) President and CEO David Hung sells 1 ...

    GuruFocus
  94. Benzinga's Top Initiations

    Benzinga
  95. Celgene, Regeneron Pharmaceutical Lead Biomed Group

    IBD
  96. Medivation Inc. (MDVN) Chief Business Officer and CFO Clarence ...

    GuruFocus
  97. UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Medivation

    Benzinga
  98. Medivation Effects 2-for-1 Stock Split

    Benzinga
  99. Three Biotech Stocks Analysts Are Keen On (MDVN, GEVA, OPTR)

    Benzinga
  100. US FDA Approves XTANDI for Patients With Metastatic Castration-Resistant ...

    Benzinga
Trading Center